Back

A Cross-Sectional Survey to Estimate the Prevalence of Family History of Colorectal, Breast, and Ovarian Cancer in Derna City, Libya

Alghazali, M. A.; AbdulKareem, E. A.; ElShaihani, A. R.; ElGabaili, R. F.; Erkhais, J. A.

2026-02-02 public and global health
10.64898/2026.01.27.26343764 medRxiv
Show abstract

BackgroundFamily history of cancer is a well-established risk factor for several malignancies, including colorectal, breast, and ovarian cancers. Estimating the prevalence of familial cancer history is essential for identifying high-risk populations and guiding targeted prevention strategies. ObjectiveThis study aimed to estimate the prevalence of family history of colorectal, breast, and ovarian cancer among residents of Derna City, Libya. MethodsA cross-sectional survey was conducted among 300 participants aged 17-45 years, selected using stratified random sampling. Data were collected through structured questionnaires covering sociodemographic characteristics and family history of cancer. Descriptive statistical analyses were performed to estimate prevalence rates. ResultsThe mean age of participants was 24.65 {+/-} 4.70 years, with the majority under 25 years of age (67.3%). Females constituted 79.9% of the sample, and most participants had a university-level education (93.5%). A family history of breast cancer was reported by 30.0% of participants, followed by colorectal cancer (23.3%) and ovarian cancer (13.3%). These findings indicate a substantial proportion of individuals with potential genetic susceptibility to these cancers within the study population. ConclusionA notable prevalence of family history of colorectal, breast, and ovarian cancers was observed in Derna City. These results underscore the importance of incorporating family history assessment into routine healthcare practice and strengthening genetic counseling, screening, and public awareness programs. Targeted prevention strategies may help reduce the burden of hereditary cancers in this region.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 3%
28.5%
2
BMC Cancer
52 papers in training set
Top 0.1%
10.4%
3
Cureus
67 papers in training set
Top 0.4%
7.0%
4
BMC Public Health
147 papers in training set
Top 0.5%
6.6%
50% of probability mass above
5
Cancer Medicine
24 papers in training set
Top 0.1%
6.5%
6
Journal of Public Health
23 papers in training set
Top 0.2%
2.1%
7
Frontiers in Public Health
140 papers in training set
Top 4%
1.9%
8
BMJ Open
554 papers in training set
Top 8%
1.9%
9
Scientific Reports
3102 papers in training set
Top 56%
1.7%
10
International Journal of Cancer
42 papers in training set
Top 0.6%
1.7%
11
PLOS Global Public Health
293 papers in training set
Top 4%
1.7%
12
International Journal of Environmental Research and Public Health
124 papers in training set
Top 4%
1.5%
13
Epidemiology and Infection
84 papers in training set
Top 2%
1.4%
14
Diagnostics
48 papers in training set
Top 1%
1.4%
15
BMC Research Notes
29 papers in training set
Top 0.2%
1.3%
16
JMIRx Med
31 papers in training set
Top 1%
1.1%
17
JMIR Research Protocols
18 papers in training set
Top 1%
1.0%
18
Frontiers in Medicine
113 papers in training set
Top 5%
0.9%
19
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
0.8%
20
Disaster Medicine and Public Health Preparedness
16 papers in training set
Top 1%
0.8%
21
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.7%
22
International Journal of Epidemiology
74 papers in training set
Top 3%
0.7%
23
Current Developments in Nutrition
15 papers in training set
Top 0.9%
0.7%
24
Journal of Racial and Ethnic Health Disparities
11 papers in training set
Top 0.5%
0.7%
25
Vaccines
196 papers in training set
Top 3%
0.7%
26
BMC Infectious Diseases
118 papers in training set
Top 6%
0.7%
27
JMIR Formative Research
32 papers in training set
Top 2%
0.7%
28
F1000Research
79 papers in training set
Top 6%
0.5%
29
PeerJ
261 papers in training set
Top 18%
0.5%
30
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.9%
0.5%